117 related articles for article (PubMed ID: 31805599)
1. Heart Failure and Cardiac Events: Is a Consecutive Measurement of Biomarkers a Simple and Practical Approach?
Rivera-Caravaca JM; Esteve-Pastor MA
Thromb Haemost; 2019 Dec; 119(12):1891-1893. PubMed ID: 31805599
[No Abstract] [Full Text] [Related]
2. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
[TBL] [Abstract][Full Text] [Related]
3. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
Pawlak K; Buraczewska-Buczko A; Mysliwiec M; Pawlak D
Am J Med Sci; 2010 Jan; 339(1):5-9. PubMed ID: 19926968
[TBL] [Abstract][Full Text] [Related]
4. Impact of expression of the uPA system in sarcomas.
Taubert H; Magdolen V; Kotzsch M
Biomark Med; 2013 Jun; 7(3):473-80. PubMed ID: 23734810
[TBL] [Abstract][Full Text] [Related]
5. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
[TBL] [Abstract][Full Text] [Related]
6. The urokinase system in patients with intermittent and persistent allergic rhinitis.
Kasperska-Zajac A; Brzoza Z; Rogala B
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):685-8. PubMed ID: 18832910
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
8. Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease.
Yeh YH; Wang PH; Lin LY; Tee YT; Chou MC; Yang SF; Tsai HT
Clin Chim Acta; 2013 Jan; 415():138-44. PubMed ID: 23117033
[TBL] [Abstract][Full Text] [Related]
9. Blood urokinase plasminogen activator system in chronic urticaria.
Kasperska-Zajac A; Brzoza Z; Rogala B
Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
[TBL] [Abstract][Full Text] [Related]
10. From lactate to soluble urokinase plasminogen activator receptor: The journey for ideal cardiac biomarker: Are we there in 2016?
Kapoor PM
Ann Card Anaesth; 2016; 19(2):211-3. PubMed ID: 27052058
[No Abstract] [Full Text] [Related]
11. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
Moniwa N
Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
[TBL] [Abstract][Full Text] [Related]
12. Soluble urokinase plasminogen activation receptor--An emerging new biomarker of cardiovascular disease and critical illness.
Cyrille NB; Villablanca PA; Ramakrishna H
Ann Card Anaesth; 2016; 19(2):214-6. PubMed ID: 27052059
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
[TBL] [Abstract][Full Text] [Related]
14. Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients.
Chung HC; Rha SY; Park JO; Yoo NC; Kim JH; Roh JK; Min JS; Lee KS; Kim BS; Kim JJ
Breast Cancer Res Treat; 1998 May; 49(1):41-50. PubMed ID: 9694610
[TBL] [Abstract][Full Text] [Related]
15. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
16. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn).
Bandinelli F; Bartoli F; Perfetto E; Del Rosso A; Moggi-Pignone A; Guiducci S; Cinelli M; Fatini C; Generini S; Gabrielli A; Giacomelli R; Maddali Bongi S; Abbate R; Del Rosso M; Matucci Cerinic M
Clin Exp Rheumatol; 2005; 23(5):671-7. PubMed ID: 16173244
[TBL] [Abstract][Full Text] [Related]
18. [Dynamic changes in plasma levels of urokinase type plasminogen activator and urokinase type plasminogen activator receptor in patients with systemic inflammatory response syndrome].
Wu XL; Yu L; Long D; Yang JH; Zhang YC; Geng F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):478-81. PubMed ID: 21878172
[TBL] [Abstract][Full Text] [Related]
19. [The analysis of plasma Urokinase-type plasminogen activator and Urokinase-type plasminogen activator receptor which unknown factor nosebleed patients].
Zhan L; Huang G; Wen W; Zhou Y; Tang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Nov; 21(22):1029-30, 1050. PubMed ID: 18257282
[TBL] [Abstract][Full Text] [Related]
20. Urokinase plasminogen activator system in humans with stable coronary artery disease.
Krasnikova TL; Parfyonova Y; Alekseeva IA; Arefieva TI; Mukhina SA; Dobrovolsky AB; Titaeva Y; Lyakishev AA; Resink TJ; Erne P; Tkachuk VA
Clin Exp Pharmacol Physiol; 1999 Apr; 26(4):354-7. PubMed ID: 10225148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
